We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.
List of manufacturers and their medical devices which have been granted an exemption by the MHRA. The list also includes manufacturers whose exemption expired or was cancelled. This information will be listed for 2 months after expiry or cancellation.
Latest updates on SARS-CoV-2 variants detected in the UK.
Information for healthcare professionals and the public about COVID-19 Vaccine AstraZeneca.
Information for healthcare professionals and the public about the COVID-19 Vaccine SKYCovion
The new COVID-19 vaccine from SK Chemicals, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
Information for healthcare professionals and the public about the COVID-19 Vaccine Janssen
Describes obstacles experienced by Blackpool Council and its public health team in supporting testing, and local responses implemented to overcome challenges.
People at greatest risk of serious illness from COVID-19 are eligible for a vaccine.
The COVID-19 vaccine from Moderna has met the MHRA’s required safety, quality and effectiveness standards to be authorised for use in this age group
Information for healthcare professionals and the public on Moderna's bivalent vaccines. Information on the original Spikevax COVID-19 vaccine can found on a separate page (link below)
Information for healthcare professionals and the public about the COVID-19 vaccine Nuvaxovid.
The vaccine was approved after it was found to meet the UK regulator's standards of safety, quality and effectiveness
The vaccine was approved after it was found to meet the MHRA’s standards of safety, quality and effectiveness.
The new vaccine from HIPRA Human Health has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
The offer of a first or second dose of COVID-19 vaccine will end on 30 June 2023 for most people.
A letter from the Cabinet Office to the Covid-19 Inquiry
The UK Health Security Agency is encouraging those at higher risk of flu and COVID-19 to make a new year’s resolution to get winter strong.
Public consultation supports proposal to update 3 regulations that ensure the safe and effective delivery of COVID-19 and influenza vaccination programmes.
A witness statement from the Cabinet Office to the Covid-19 Inquiry
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.